Literature DB >> 25412850

Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies.

Michelle D Reid1, Pelin Bagci2, Nobuyuki Ohike3, Burcu Saka4, Ipek Erbarut Seven2, Nevra Dursun5, Serdar Balci6, Hasan Gucer7, Kee-Taek Jang8, Takuma Tajiri9, Olca Basturk10, So Yeon Kong11, Michael Goodman11, Gizem Akkas1, Volkan Adsay1.   

Abstract

Ki67 index is now an essential part of classification of pancreatic neuroendocrine tumors. However, its adaptation into daily practice has been fraught with challenges related to counting methodology. In this study, three reviewers used four counting methodologies to calculate Ki67 index in 68 well-differentiated pancreatic neuroendocrine tumors: (1) 'eye-ball' estimation, which has been advocated as reliable and is widely used; (2) automated counting by image analyzer; (3) manual eye-counting (eye under a microscope without a grid); and (4) manual count of camera-captured/printed image. Pearson's correlation (R) was used to measure pair-wise correlation among three reviewers using all four methodologies. Average level of agreement was calculated using mean of R values. The results showed that: (1) 'eye-balling' was least expensive and fastest (average time <1 min) but had poor reliability and reproducibility. (2) Automated count was the most expensive and least practical with major impact on turnaround time (limited by machine and personnel accessibility), and, more importantly, had inaccuracies in overcounting unwanted material. (3) Manual eye count had no additional cost, averaged 6 min, but proved impractical and poorly reproducible. (4) Camera-captured/printed image was most reliable, had highest reproducibility, but took longer than 'eye-balling'. In conclusion, based on its comparatively low cost/benefit ratio and reproducibility, camera-captured/printed image appears to be the most practical for calculating Ki67 index. Although automated counting is generally advertised as the gold standard for index calculation, in this study it was not as accurate or cost-effective as camera-captured/printed image and was highly operator-dependent. 'Eye-balling' produces highly inaccurate and unreliable results, and is not recommended for routine use.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25412850      PMCID: PMC4460192          DOI: 10.1038/modpathol.2014.156

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  17 in total

1.  Computer-assisted pathological immunohistochemistry scoring is more time-effective than conventional scoring, but provides no analytical advantage.

Authors:  Chee Wee Ong; Lay Gek Kim; Hui Hui Kong; Lai Yee Low; Ting Ting Wang; Srivastava Supriya; Manickam Kathiresan; Richie Soong; Manuel Salto-Tellez
Journal:  Histopathology       Date:  2010-03       Impact factor: 5.087

2.  NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

Authors:  Matthew H Kulke; Lowell B Anthony; David L Bushnell; Wouter W de Herder; Stanley J Goldsmith; David S Klimstra; Stephen J Marx; Janice L Pasieka; Rodney F Pommier; James C Yao; Robert T Jensen
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

3.  Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification.

Authors:  Zhaohai Yang; Laura H Tang; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2011-06       Impact factor: 6.394

Review 4.  Endocrine tumours of the pancreas.

Authors:  Caroline S Verbeke
Journal:  Histopathology       Date:  2010-05       Impact factor: 5.087

5.  Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.

Authors:  David S Klimstra; Irvin R Modlin; N Volkan Adsay; Runjan Chetty; Vikram Deshpande; Mithat Gönen; Robert T Jensen; Mark Kidd; Matthew H Kulke; Ricardo V Lloyd; Cesar Moran; Steven F Moss; Kjell Oberg; Dermot O'Toole; Guido Rindi; Marie E Robert; Saul Suster; Laura H Tang; Chin-Yuan Tzen; Mary Kay Washington; Betram Wiedenmann; James Yao
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

6.  The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum.

Authors:  Lowell B Anthony; Jonathan R Strosberg; David S Klimstra; William J Maples; Thomas M O'Dorisio; Richard R P Warner; Gregory A Wiseman; Al B Benson; Rodney F Pommier
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

7.  The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum.

Authors:  J Philip Boudreaux; David S Klimstra; Manal M Hassan; Eugene A Woltering; Robert T Jensen; Stanley J Goldsmith; Charles Nutting; David L Bushnell; Martyn E Caplin; James C Yao
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

8.  Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors.

Authors:  Anne Couvelard; Lydia Deschamps; Philippe Ravaud; Gabriel Baron; Alain Sauvanet; Olivia Hentic; Nathalie Colnot; Valérie Paradis; Jacques Belghiti; Pierre Bedossa; Philippe Ruszniewski
Journal:  Mod Pathol       Date:  2008-11-07       Impact factor: 7.842

9.  Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study.

Authors:  James C Yao; Alexandria T Phan; David Z Chang; Robert A Wolff; Kenneth Hess; Sanjay Gupta; Carmen Jacobs; Jeannette E Mares; Andrea N Landgraf; Asif Rashid; Funda Meric-Bernstam
Journal:  J Clin Oncol       Date:  2008-09-10       Impact factor: 44.544

10.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

View more
  59 in total

Review 1.  Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Günter Klöppel; Stefano La Rosa
Journal:  Virchows Arch       Date:  2017-11-13       Impact factor: 4.064

Review 2.  Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.

Authors:  Romain Coriat; Thomas Walter; Benoît Terris; Anne Couvelard; Philippe Ruszniewski
Journal:  Oncologist       Date:  2016-07-08

Review 3.  Neuroendocrine Pulmonary Tumors of Low, Intermediate and High Grade: Anatomopathological Diagnosis-Prognostic and Predictive Factors.

Authors:  José Manuel Cameselle-Teijeiro; José Antonio Mato Mato; Ovidio Fernández Calvo; Jesús García Mata
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

4.  Ki-67 expression in pulmonary tumors.

Authors:  Lucian R Chirieac
Journal:  Transl Lung Cancer Res       Date:  2016-10

5.  Detecting Hematopoietic Stem Cell Proliferation Using BrdU Incorporation.

Authors:  Katie A Matatall; Claudine S Kadmon; Katherine Y King
Journal:  Methods Mol Biol       Date:  2018

Review 6.  Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.

Authors:  Silvia Uccella; Stefano La Rosa; Marco Volante; Mauro Papotti
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

7.  Site-Specific Genomic Alterations in a Well-Differentiated Pancreatic Neuroendocrine Tumor With High-Grade Progression.

Authors:  David R Martin; Elisa LaBauve; Joseph M Pomo; Vi K Chiu; Joshua A Hanson; Rama R Gullapalli
Journal:  Pancreas       Date:  2018-04       Impact factor: 3.327

8.  KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment?

Authors:  Federica Grillo; Luca Valle; Diego Ferone; Manuela Albertelli; Maria Pia Brisigotti; Giuseppe Cittadini; Alessandro Vanoli; Roberto Fiocca; Luca Mastracci
Journal:  Endocrine       Date:  2017-07-19       Impact factor: 3.633

9.  Interlaboratory variability of MIB1 staining in well-differentiated pancreatic neuroendocrine tumors.

Authors:  Annika Blank; Laura Wehweck; Ilaria Marinoni; Laura Amanda Boos; Frank Bergmann; Anja Maria Schmitt; Aurel Perren
Journal:  Virchows Arch       Date:  2015-09-17       Impact factor: 4.064

Review 10.  Classification of pulmonary neuroendocrine tumors: new insights.

Authors:  Giuseppe Pelosi; Angelica Sonzogni; Sergio Harari; Adriana Albini; Enrica Bresaola; Caterina Marchiò; Federica Massa; Luisella Righi; Gaia Gatti; Nikolaos Papanikolaou; Namrata Vijayvergia; Fiorella Calabrese; Mauro Papotti
Journal:  Transl Lung Cancer Res       Date:  2017-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.